Copyright
©2012 Baishideng.
World J Hepatol. Sep 27, 2012; 4(9): 256-261
Published online Sep 27, 2012. doi: 10.4254/wjh.v4.i9.256
Published online Sep 27, 2012. doi: 10.4254/wjh.v4.i9.256
Outcome | Patients (n = 320) |
Death | 292 (91) |
Overall survival | |
Median (95% CI) (mo) | 6.8 (5.8-7.7) |
1-yr survival rate | 32 |
2-yr survival rate | 13 |
BCLC A (early stage) survival | |
Median (95% CI) (mo) | 33 (20-46) |
1-yr survival rate | 100 |
2-yr survival rate | 57 |
3-yr survival rate | 41 |
BCLC B (intermediate stage) survival | |
Median (95% CI) (mo) | 17.4 (14.8-20) |
1-yr survival rate | 79 |
2-yr survival rate | 22 |
3-yr survival rate | 5 |
BCLC C (advanced stage) survival | |
Median (95% CI) (mo) | 6.9 (6.3-7.3) |
1-yr survival rate | 12 |
BCLC D (end-stage) survival | |
Median (95% CI) (mo) | 1.8 (1.2-2.4) |
1-yr survival rate | 0 |
- Citation: Cabibbo G, Maida M, Genco C, Parisi P, Peralta M, Antonucci M, Brancatelli G, Cammà C, Craxì A, Di Marco V. Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study. World J Hepatol 2012; 4(9): 256-261
- URL: https://www.wjgnet.com/1948-5182/full/v4/i9/256.htm
- DOI: https://dx.doi.org/10.4254/wjh.v4.i9.256